Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Change in Accured Expenses (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Change in Accured Expenses for 17 consecutive years, with $23.0 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 529.48% to $23.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.7 million through Dec 2025, up 1099.4% year-over-year, with the annual reading at $26.7 million for FY2025, 1099.4% up from the prior year.
  • Change in Accured Expenses hit $23.0 million in Q4 2025 for Integra Lifesciences Holdings, up from $5.8 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $23.0 million in Q4 2025 to a low of -$19.2 million in Q1 2024.
  • Historically, Change in Accured Expenses has averaged $2.7 million across 5 years, with a median of $3.8 million in 2023.
  • Biggest five-year swings in Change in Accured Expenses: surged 1944.11% in 2022 and later crashed 380.33% in 2024.
  • Year by year, Change in Accured Expenses stood at -$984000.0 in 2021, then soared by 1944.11% to $18.1 million in 2022, then plummeted by 89.46% to $1.9 million in 2023, then tumbled by 380.33% to -$5.4 million in 2024, then skyrocketed by 529.48% to $23.0 million in 2025.
  • Business Quant data shows Change in Accured Expenses for IART at $23.0 million in Q4 2025, $5.8 million in Q3 2025, and $15.9 million in Q2 2025.